← FDA Drug Approvals (Drugs@FDA)
OXYBUTYNIN CHLORIDE
ANDA · Abbreviated New Drug Application (Generic) · Sponsor: REGCON HOLDINGS · Approved 2022-07-14
Drug application
- FDA Application #
ANDA213550- Application type
- Abbreviated New Drug Application (Generic)
- Brand name
- OXYBUTYNIN CHLORIDE
- Generic name
- Oxybutynin Chloride
- Active ingredients
- OXYBUTYNIN CHLORIDE
- Dosage form
- TABLET
- Route
- ORAL
- Marketing status
- Prescription
- Sponsor
- REGCON HOLDINGS
- First approval
- 2022-07-14
Source
- Authoritative
- Drugs@FDA application overview
- Machine
- JSON-LD · Markdown